Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372252 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
The key intermediate, 4-chloro-5-iodo-3-pyridinecarbonitrile, allowed for ready optimization of the PKCθ inhibitory activity of a series of 3-pyridinecarbonitriles. Analog 13b with a 4-methylindol-5-ylamino group at C-4 and a 4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl group at C-5 had an IC50 value of 7.4 nM for the inhibition of PKCθ.
Graphical abstractAnalog 13b with a 4-methylindol-5-ylamino group at C-4 and a 4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl group at C-5 had an IC50 value of 7.4 nM for the inhibition of PKCθ.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Diane H. Boschelli, Daniel Wang, Amar S. Prashad, Joan Subrath, Biqi Wu, Chuan Niu, Julie Lee, Xiaoke Yang, Agnes Brennan, Divya Chaudhary,